711 related articles for article (PubMed ID: 19661842)
1. Validation of the APTIMA Combo 2 assay for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in SurePath liquid-based pap test samples taken with different collection devices.
Chernesky M; Jang D; Smieja M; Portillo E; Ewert R; Pritchard C; MacEachern D; Doucette C; MacDonald A; Kapala J; Sumner J; Hill C
Sex Transm Dis; 2009 Sep; 36(9):581-3. PubMed ID: 19661842
[TBL] [Abstract][Full Text] [Related]
2. Detection of Chlamydia trachomatis and Neisseria gonorrhoeae infections in North American women by testing SurePath liquid-based Pap specimens in APTIMA assays.
Chernesky M; Freund GG; Hook E; Leone P; D'Ascoli P; Martens M
J Clin Microbiol; 2007 Aug; 45(8):2434-8. PubMed ID: 17581931
[TBL] [Abstract][Full Text] [Related]
3. Abilities of APTIMA, AMPLICOR, and ProbeTec assays to detect Chlamydia trachomatis and Neisseria gonorrhoeae in PreservCyt ThinPrep Liquid-based Pap samples.
Chernesky M; Jang D; Portillo E; Chong S; Smieja M; Luinstra K; Petrich A; Macritchie C; Ewert R; Hayhoe B; Sarabia A; Thompson F
J Clin Microbiol; 2007 Aug; 45(8):2355-8. PubMed ID: 17537943
[TBL] [Abstract][Full Text] [Related]
4. Effect of specimen order on Chlamydia trachomatis and Neisseria gonorrhoeae test performance and adequacy of Papanicolaou smear.
Ghanem KG; Koumans EH; Johnson RE; Sawyer MK; Papp JR; Unger ER; Black CM; Markowitz LE
J Pediatr Adolesc Gynecol; 2006 Feb; 19(1):23-30. PubMed ID: 16472725
[TBL] [Abstract][Full Text] [Related]
5. Comparison between the LCx Probe system and the COBAS AMPLICOR system for detection of Chlamydia trachomatis and Neisseria gonorrhoeae infections in patients attending a clinic for treatment of sexually transmitted diseases in Amsterdam, The Netherlands.
van Doornum GJ; Schouls LM; Pijl A; Cairo I; Buimer M; Bruisten S
J Clin Microbiol; 2001 Mar; 39(3):829-35. PubMed ID: 11230391
[TBL] [Abstract][Full Text] [Related]
6. Nucleic acid amplification tests in the diagnosis of chlamydial and gonococcal infections of the oropharynx and rectum in men who have sex with men.
Schachter J; Moncada J; Liska S; Shayevich C; Klausner JD
Sex Transm Dis; 2008 Jul; 35(7):637-42. PubMed ID: 18520976
[TBL] [Abstract][Full Text] [Related]
7. High analytical sensitivity and low rates of inhibition may contribute to detection of Chlamydia trachomatis in significantly more women by the APTIMA Combo 2 assay.
Chernesky M; Jang D; Luinstra K; Chong S; Smieja M; Cai W; Hayhoe B; Portillo E; Macritchie C; Main C; Ewert R
J Clin Microbiol; 2006 Feb; 44(2):400-5. PubMed ID: 16455891
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of the m2000 automated sample preparation and multiplex real-time PCR system for detection of Chlamydia trachomatis and Neisseria gonorrhoeae.
Marshall R; Chernesky M; Jang D; Hook EW; Cartwright CP; Howell-Adams B; Ho S; Welk J; Lai-Zhang J; Brashear J; Diedrich B; Otis K; Webb E; Robinson J; Yu H
J Clin Microbiol; 2007 Mar; 45(3):747-51. PubMed ID: 17202273
[TBL] [Abstract][Full Text] [Related]
9. Vaginal swabs are the specimens of choice when screening for Chlamydia trachomatis and Neisseria gonorrhoeae: results from a multicenter evaluation of the APTIMA assays for both infections.
Schachter J; Chernesky MA; Willis DE; Fine PM; Martin DH; Fuller D; Jordan JA; Janda W; Hook EW
Sex Transm Dis; 2005 Dec; 32(12):725-8. PubMed ID: 16314767
[TBL] [Abstract][Full Text] [Related]
10. Multicenter evaluation of the BDProbeTec ET System for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine specimens, female endocervical swabs, and male urethral swabs.
Van Der Pol B; Ferrero DV; Buck-Barrington L; Hook E; Lenderman C; Quinn T; Gaydos CA; Lovchik J; Schachter J; Moncada J; Hall G; Tuohy MJ; Jones RB
J Clin Microbiol; 2001 Mar; 39(3):1008-16. PubMed ID: 11230419
[TBL] [Abstract][Full Text] [Related]
11. Comparison of APTIMA COMBO 2 assay with polymerase chain reaction Roche assay for detection of Chlamydia trachomatis in endocervical swabs.
Khryanin AA; Reshetnikov OV; Vlaspolder F
Int J STD AIDS; 2007 Dec; 18(12):871-2. PubMed ID: 18073027
[No Abstract] [Full Text] [Related]
12. Clinical evaluation of a new Pap test-based method for screening of Chlamydia trachomatis and Neisseria gonorrhoeae using liquid-based cytology media.
Martens MG; Fine P; Fuller D; Ginde SY; Hook EW; Lebed J; Mena L; Taylor SN; Van Der Pol B
South Med J; 2013 Sep; 106(9):506-12. PubMed ID: 24002555
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of replacing the existing diagnostic strategy for Neisseria gonorrhoeae and Chlamydia trachomatis infections with sole molecular testing of urine specimens in a sexually transmitted infection clinic setting.
Ho MK; Lo JY; Lo AC; Cheng FK; Chan FK
Sex Transm Infect; 2009 Sep; 85(5):322-5. PubMed ID: 19406739
[TBL] [Abstract][Full Text] [Related]
14. Comparison of methods for detection of Chlamydia trachomatis and Neisseria gonorrhoeae using commercially available nucleic acid amplification tests and a liquid pap smear medium.
Koumans EH; Black CM; Markowitz LE; Unger E; Pierce A; Sawyer MK; Papp JR
J Clin Microbiol; 2003 Apr; 41(4):1507-11. PubMed ID: 12682137
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the BD Viper System with XTR Technology to the Gen-Probe APTIMA COMBO 2 Assay using the TIGRIS DTS system for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine specimens.
Mushanski LM; Brandt K; Coffin N; Levett PN; Horsman GB; Rank EL
Sex Transm Dis; 2012 Jul; 39(7):514-7. PubMed ID: 22706212
[TBL] [Abstract][Full Text] [Related]
16. Comparison of three assays for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in SurePath Pap samples and the role of pre- and postcytology testing.
Chernesky M; Jang D; Portillo E; Smieja M; Kapala J; Doucette C; Sumner J; Ewert R; MacRitchie C; Gilchrist J
J Clin Microbiol; 2012 Apr; 50(4):1281-4. PubMed ID: 22259215
[TBL] [Abstract][Full Text] [Related]
17. Multicenter study of nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in children being evaluated for sexual abuse.
Black CM; Driebe EM; Howard LA; Fajman NN; Sawyer MK; Girardet RG; Sautter RL; Greenwald E; Beck-Sague CM; Unger ER; Igietseme JU; Hammerschlag MR
Pediatr Infect Dis J; 2009 Jul; 28(7):608-13. PubMed ID: 19451856
[TBL] [Abstract][Full Text] [Related]
18. Ability of new APTIMA CT and APTIMA GC assays to detect Chlamydia trachomatis and Neisseria gonorrhoeae in male urine and urethral swabs.
Chernesky MA; Martin DH; Hook EW; Willis D; Jordan J; Wang S; Lane JR; Fuller D; Schachter J
J Clin Microbiol; 2005 Jan; 43(1):127-31. PubMed ID: 15634960
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the Gen-Probe APTIMA Combo 2 assay to the AMPLICOR CT/NG assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine samples from Australian men and women.
Lowe P; O'Loughlin P; Evans K; White M; Bartley PB; Vohra R
J Clin Microbiol; 2006 Jul; 44(7):2619-21. PubMed ID: 16825397
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the APTIMA Combo 2 Assay using self-administered vaginal swabs for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae.
Crucitti T; De Deken B; Smet H; Cuylaerts V; Abdellati S; Vuylsteke B
Diagn Microbiol Infect Dis; 2013 Jul; 76(3):385-6. PubMed ID: 23598167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
